PE20071016A1 - Formas cristalinas de n-(benzo[b]tien-3-ilmetil)-sulfamida - Google Patents

Formas cristalinas de n-(benzo[b]tien-3-ilmetil)-sulfamida

Info

Publication number
PE20071016A1
PE20071016A1 PE2007000186A PE2007000186A PE20071016A1 PE 20071016 A1 PE20071016 A1 PE 20071016A1 PE 2007000186 A PE2007000186 A PE 2007000186A PE 2007000186 A PE2007000186 A PE 2007000186A PE 20071016 A1 PE20071016 A1 PE 20071016A1
Authority
PE
Peru
Prior art keywords
sulfamide
benzo
ilmetyl
crystalline forms
ilmethyl
Prior art date
Application number
PE2007000186A
Other languages
English (en)
Inventor
Nagy Fawzy
Michael H Parker
Allen B Reitz
Bruce E Maryanoff
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38066512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20071016(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PE20071016A1 publication Critical patent/PE20071016A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A FORMAS CRISTALINAS ANHIDRAS DEL COMPUESTO N-(BENZO[b]TIEN-3-ILMETIL)-SULFAMIDA DE FORMULA (I), DONDE LOS PICOS DE DIFRACCION DE POLVO DE RAYOS X EXPRESADOS EN 2 DE LA FORMA CRISTALINA ANHIDRA I SON: 4,44; 5,92; 13,21; 13,38; 14,80; 16,76; 17,81; 19,00; 21,43; 22,29; ENTRE OTROS. SE REFIERE TAMBIEN A UNA FORMA CRISTALINA SOLVATADA DE 1,4-DIOXANO DEL COMPUESTO N-(BENZO[b]TIEN-3-ILMETIL)-SULFAMIDA Y A UN PROCEDIMIENTO DE PREPARACION. DICHAS FORMAS CRISTALINAS SON UTILES EN EL TRATAMIENTO DE EPILEPSIA
PE2007000186A 2006-02-22 2007-02-20 Formas cristalinas de n-(benzo[b]tien-3-ilmetil)-sulfamida PE20071016A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77572406P 2006-02-22 2006-02-22

Publications (1)

Publication Number Publication Date
PE20071016A1 true PE20071016A1 (es) 2007-10-24

Family

ID=38066512

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000186A PE20071016A1 (es) 2006-02-22 2007-02-20 Formas cristalinas de n-(benzo[b]tien-3-ilmetil)-sulfamida

Country Status (6)

Country Link
US (1) US20070232685A1 (es)
AR (1) AR059596A1 (es)
PE (1) PE20071016A1 (es)
TW (1) TW200738669A (es)
UY (1) UY30171A1 (es)
WO (1) WO2007098486A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CA2609185A1 (en) 2005-05-20 2006-11-30 Ahmed F. Abdel-Magid Process for preparation of sulfamide derivatives
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
EP2026790A2 (en) 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
CN101842364A (zh) * 2007-08-08 2010-09-22 詹森药业有限公司 用于治疗癫痫的磺酰胺衍生物
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
KR20100126535A (ko) * 2008-03-26 2010-12-01 얀센 파마슈티카 엔.브이. 벤조-융합된 헤테로아릴 설파메이트의 제조방법 및 ｎ-(((2ｓ)-6-클로로-2,3-다이하이드로-1,4-벤조다이옥신-2-일)메틸-설파미드의 결정형
MX2011000090A (es) 2008-06-23 2011-03-02 Janssen Pharmaceutica Nv Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]diox in-2-ilmetil)sulfamida.
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
WO1997019682A1 (en) * 1995-12-01 1997-06-05 Synaptic Pharmaceutical Corporation Aryl sulfonamide and sulfamide derivatives and uses thereof
CA2448160A1 (en) * 2001-05-25 2002-12-05 Queen's University At Kingston Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
US20030047001A1 (en) * 2001-08-28 2003-03-13 Grace Liao Ball speed detecting assembly
CN1897950A (zh) * 2003-10-14 2007-01-17 惠氏公司 稠合芳基和杂芳基衍生物及其使用方法
AR049646A1 (es) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
MX2007002309A (es) * 2004-08-24 2007-10-08 Johnson & Johnson Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos.
CA2609185A1 (en) * 2005-05-20 2006-11-30 Ahmed F. Abdel-Magid Process for preparation of sulfamide derivatives

Also Published As

Publication number Publication date
WO2007098486A1 (en) 2007-08-30
UY30171A1 (es) 2007-07-31
AR059596A1 (es) 2008-04-16
TW200738669A (en) 2007-10-16
US20070232685A1 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
PE20071016A1 (es) Formas cristalinas de n-(benzo[b]tien-3-ilmetil)-sulfamida
PE20060372A1 (es) Forma cristalina de clorhidrato de (-)-(1r, 2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol
ECSP088184A (es) Derivados de benzoquinazolina y su uso en el tratamiento de enfermedades óseas
BRPI0411939A (pt) derivados de propionamida úteis como moduladores de receptores de androgênio
PE20090696A1 (es) Formas cristalinas de saxagliptina y procesos para preparar las mismas
PE20081251A1 (es) Formas cristalinas del acido (3s)-3-[n-(n'-(2-terc-butilfenil)oxamil)alaninil]amino-5-(2',3',5',6'-tetrafluorofenoxi)-4-oxopentanoico
PE20110060A1 (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
NI200900219A (es) DERIVADOS DE BENCIMIDAZOL Caso: PC 33611A
TW200626068A (en) Active compounds for seed treatment
MY153985A (en) Aminotriazole derivatives as alx agonists
PA8544901A1 (es) Derivados de oxazol
RU2013111077A (ru) Дипептидное пролекарство, его применение и лекарственное средство
MY153921A (en) Aminopyrazole derivatives
GT200600086A (es) Forma cristalina de gamma-d del clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
DOP2009000266A (es) Compuestos quimicos
MX2011012739A (es) Derivados fluorados de aminotriazol.
CO6300898A2 (es) Sales y polimorfos de 9-(2,2-dimetil-propil-aminometil)-minociclina
UY32731A (es) Nuevos derivados de piperidin-ilidenaminooxi-piperidin, composiciones farmacéuticas y métodos relacionados con ellos
CR11360A (es) Benzotiazoles como moduladores del receptor de grelina
PE20081556A1 (es) Formas cristalinas de glyt1
IN2012DN00765A (es)
PE20120535A1 (es) 3-amino-2-mercaptoquinolina sustituida como modulador de kcnq2/3
CL2010000281A1 (es) Formulacion oral en forma de tableta de 9-[(2,2-dimetil-propilamino)-metil]-minociclina; metodo de preparacion; formulacion inyectable del mismo; utiles en el tratamiento de una infeccion.
PE20090045A1 (es) Docetaxel cristalino anhidro estable y metodo para la preparacion del mismo
ECSP10010499A (es) Proceso para la preparación de sulfamatos de heteroarilo benzofusionado y la forma cristalina de n-(((2s)-6-cloro-2,3-dihidro-1,4-benzodioxin-2il)metil-sulfamida

Legal Events

Date Code Title Description
FC Refusal